- Home
- EAD vs TECH Comparison
EAD vs TECH Comparison
Compare EAD & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EAD | TECH |
|---|---|---|
| Founded | 2003 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.8M | 9.2B |
| IPO Year | N/A | 1989 |
Fundamental Metrics
Financial Performance| Metric | EAD | TECH |
|---|---|---|
| Price | $6.80 | $64.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $70.46 |
| AVG Volume (30 Days) | 178.9K | ★ 1.6M |
| Earning Date | 01-01-0001 | 02-04-2026 |
| Dividend Yield | ★ 8.91% | 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $1,216,732,000.00 |
| Revenue This Year | N/A | $2.33 |
| Revenue Next Year | N/A | $7.05 |
| P/E Ratio | ★ N/A | $133.64 |
| Revenue Growth | N/A | ★ 3.85 |
| 52 Week Low | $5.69 | $46.01 |
| 52 Week High | $6.81 | $79.28 |
Technical Indicators
Market Signals| Indicator | EAD | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 63.40 |
| Support Level | $6.75 | $58.40 |
| Resistance Level | $6.84 | $66.48 |
| Average True Range (ATR) | 0.04 | 1.56 |
| MACD | 0.01 | 0.76 |
| Stochastic Oscillator | 66.73 | 75.62 |
Price Performance
Historical ComparisonAbout EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.